University of Pittsburgh; Pittsburgh, PA.
University of Illinois Cancer Center at University of Illinois at Chicago, IL.
Ethn Dis. 2020 Apr 2;30(Suppl 1):167-176. doi: 10.18865/ed.30.S1.167. eCollection 2020.
We assessed feasibility of an educational program designed to enhance stakeholder knowledge and perceptions of pharmacogenomics at a federally qualified health center (FQHC).
FQHCs have a rich history of providing care to the underserved, but often are not represented by studies evaluating cutting-edge concepts. We used a novel educational platform to provide participatory genomic testing and classroom education. We assessed participant knowledge and perceptions using questionnaires between May and July 2018.
We partnered with a FQHC affiliated with an academic medical center in Chicago.
Using convenience sampling, we recruited 20 providers and 10 community members for a feasibility study. Providers included physicians, physician extenders, community health workers, and patient health navigators. Community members were patients, supporters, and/or FQHC advisory board members.
Participants had the option to undergo personal genomic testing. Online educational modules included basic genetics, cardiovascular pharmacogenomics, and personalized medicine. Education concluded in a 2-hour live course with case-based discussions.
Our main outcome was testing pilot feasibility. Baseline knowledge and perceptions were compared with post-intervention assessments using descriptive statistics, t tests (or Wilcoxon rank-sum) for continuous variables and chi-squared (or Fisher's exact) for categorical variables.
We found that attitudes toward the intervention were positive and remained so after intervention. Our intervention was both feasible and acceptable. Genomics knowledge increased for nearly all participants.
We have determined that a pharmacogenomics educational program tailored for an underrepresented community is feasible and acceptable. Outcomes will advise methodology for larger implementation studies.
我们评估了一个旨在增强利益相关者对联邦合格健康中心(FQHC)中药物基因组学的知识和看法的教育计划的可行性。
FQHC 有着为服务不足人群提供护理的悠久历史,但在评估前沿概念的研究中往往没有代表性。我们使用一种新颖的教育平台来提供参与式基因组测试和课堂教育。我们在 2018 年 5 月至 7 月期间使用问卷调查评估参与者的知识和看法。
我们与一家隶属于芝加哥学术医疗中心的 FQHC 合作。
使用便利抽样法,我们招募了 20 名提供者和 10 名社区成员进行可行性研究。提供者包括医生、医生助理、社区卫生工作者和患者健康导航员。社区成员是患者、支持者和/或 FQHC 顾问委员会成员。
参与者可以选择进行个人基因组测试。在线教育模块包括基础遗传学、心血管药物基因组学和个性化医学。教育以 2 小时的现场课程结束,包括基于案例的讨论。
我们的主要结果是测试试点的可行性。使用描述性统计、连续变量的 t 检验(或 Wilcoxon 秩和检验)和分类变量的卡方检验(或 Fisher 精确检验)比较干预前后的基线知识和看法。
我们发现,对干预的态度是积极的,并且在干预后仍然如此。我们的干预既可行又可接受。几乎所有参与者的基因组学知识都有所增加。
我们已经确定,针对代表性不足的社区量身定制的药物基因组学教育计划是可行且可接受的。结果将为更大规模的实施研究提供方法学建议。